BioBoston Consulting

Regulatory Strategy & Submissions

Why Regulatory Strategy Matters for Life Sciences Companies

Bringing a new drug, biologic, or medical device to market is a complex journey that requires more than innovation, it requires a well-defined regulatory strategy. Without the right approach, even groundbreaking therapies can face delays, additional costs, or rejection by regulatory authorities. At BioBoston Consulting, we specialize in helping life sciences companies navigate this process […]

Quality Assurance & Regulatory Compliance

Gap assessment and remediation services for compliance

In today’s competitive life sciences industry, success is defined not only by innovation but also by quality and compliance. For organizations developing pharmaceuticals, biologics, or medical devices, ensuring product safety, patient protection, and regulatory approval is critical. At BioBoston Consulting, we specialize in Quality Assurance (QA) and Regulatory Compliance services designed to safeguard excellence, reduce […]

IND Application Consulting | FDA Investigational New Drug

IND dossier gap assessment and compliance review

In the highly regulated realm of drug development, navigating regulatory pathways is critical to advancing your innovative therapies. The Investigational New Drug (IND) Application is one such pivotal milestone—an essential bridge between preclinical research and first-in-human clinical trials. At BioBoston Consulting, we offer expert guidance on IND preparation, ensuring that your drug development path is […]

IDE Application Consulting| Investigational Device Exemption

IDE application preparation and submission support

In the medical device industry, bringing an innovative product from concept to market requires not only strong research and development but also careful navigation of regulatory pathways. One of the most critical steps in this journey is the Investigational Device Exemption (IDE) Application. At BioBoston Consulting, we guide organizations through this complex process, ensuring regulatory […]

Internal and Supplier Audits/ Life Sciences Compliance Experts

BioBoston Consulting audit readiness training

In the life sciences industry, compliance, quality, and patient safety are non-negotiable. One of the most effective tools organizations can use to safeguard their operations is the audit process. Both Internal Audits and Supplier Audits play a critical role in ensuring regulatory compliance, identifying risks, and driving continuous improvement. At BioBoston Consulting, we specialize in […]

FDA Inspection Readiness: One Stop Solution for Life Sciences

Mock FDA inspections for GMP compliance

In the life sciences industry, few events are as critical as an FDA inspection. Whether your company is developing pharmaceuticals, biologics, or medical devices, regulatory inspections are inevitable. These inspections are designed to evaluate compliance with Good Manufacturing Practices (GMP), Good Clinical Practices (GCP), and Good Laboratory Practices (GLP). Being unprepared can result in severe […]

CDMO Vendor Selection, Qualification & Oversight

CDMO qualification audits and cGMP complia

One Stop Solution for Life Sciences In today’s fast-paced life sciences industry, partnering with a reliable Contract Development and Manufacturing Organization (CDMO) can transform your development and manufacturing processes, if the right fit is chosen. At BioBoston Consulting, we offer comprehensive CDMO Vendor Selection, Qualification & Oversight services to ensure your outsourced operations are efficient, […]

Computer System Validation (CSV): One Stop Solution for Life Sciences

Computer System Validation CSV compliance for life sciences

 One Stop Solution for Life Sciences In today’s life sciences industry, technology is at the core of innovation, operations, and compliance. From laboratory information systems and clinical trial management tools to manufacturing execution systems and electronic document management, companies rely heavily on computerized systems to streamline processes and maintain regulatory standards. However, with this reliance […]